Zydus Lifesciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ZYDUSLIFE BSE: 532321

About Zydus Lifesciences Limited

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020.

Source: Wikipedia

Key facts

BSE symbol532321
NSE symbolZYDUSLIFE
ISININE010B01027
CINL24230GJ1995PLC025878
Listing date18 Apr 2000
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorSPANJ & ASSOCIATES (Ashish C Doshi)
Registered officeZYDUS CORPORATE PARK, SCHEME NO. 63, SURVEY NO. 536, KHORAJ (GANDHINAGAR), NEAR VAISHNODEVI CIRCLE, S G HIGHWAY, AHMEDABAD-382481
Registrar & transfer agentMUFG Intime India Private Limited 5th Floor, 506 TO 508, Amarnath Business Centre ��� 1 ( ABC-1), Beside Gala Business Centre, Nr. St. Xavier���s College Corner, Off C G Road, Navrangpura, Ahmedabad - 380009

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)13,152†15,812†11,904†9,594†8,161†
Net profit3,5605,7753,442†1,529†858†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Ganesh Narayan NayakExecutive DirectorJune 30, 2026
Sharvil Pankajbhai PatelExecutive DirectorJune 30, 2026
Akhil MonappaIndependent DirectorJune 30, 2026
Bhadresh Kantilal ShahIndependent DirectorJune 30, 2026
Konidela UpasanaIndependent DirectorJune 30, 2026
Kulin Sanjay LalbhaiIndependent DirectorJune 30, 2026
Shelina Pranav ParikhIndependent DirectorJune 30, 2026
Mukesh Mangalbhai PatelNon-Executive DirectorJune 30, 2026
Pankaj Ramanbhai PatelNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.